Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 04 - 30 tags : Treatment save search
Sarepta Therapeutics to Share Clinical Update for 30 mg/kg arm of MOMENTUM Study for SRP-5051, Its Investigational PPMO for the Treatment of Duchenne Muscular Dystrophy
Published: 2021-04-30 (Crawled : 22:00) - biospace.com/
SRPT | $115.53 -0.88% -0.9% 640K
|
Health Technology
|
| O: -0.43%
H: 1.54%
C: -0.37%
treatment duchenne
Worldwide Dry Eye Disease (DED) Industry to 2026 - by Disease, Treatment, End-user, Distribution Channel and Region
Published: 2021-04-30 (Crawled : 20:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
dry eye disease treatment eye eye disease distribution
Global Allergy Treatment Markets, 2020-2021 & Forecast to 2028: Increasing Adoption of Immunotherapy in Allergy Treatment & Developments in Food Allergy Treatments
Published: 2021-04-30 (Crawled : 19:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
food treatment immunotherapy therapy
Worldwide Neurological Diseases Treatment Industry to 2029 - Featuring Novartis, GlaxoSmithKline and Bayer Among Others
Published: 2021-04-30 (Crawled : 16:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.48%
H: 0.57%
C: -0.44%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.61%
H: 0.4%
C: -1.03%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 3.7%
H: 2.42%
C: -0.38%
disease treatment neurological
Praxis Precision Medicines Receives Orphan Drug Designation for PRAX-562 for the Treatment of SCN2A-DEEPRAX-562 Phase 2 clinical trial for treatment of DEEs expected to initiate in first half of 2022
Published: 2021-04-30 (Crawled : 14:00) - biospace.com/
PRAX | $46.88 0.62% 0.62% 350K
|
Health Technology
|
| O: -2.42%
H: 1.4%
C: -2.48%
treatment phase 2 drug trial designation
Lantheus Grants Allegheny Health Network Exclusive Rights for the Use of its Microbubbles in Combination with Ultrasound Assisted Gene Therapy for the Development of a Proposed Treatment for Xerostomia
Published: 2021-04-30 (Crawled : 14:00) - biospace.com/
LNTH | $63.8 2.36% 2.3% 800K
|
Health Technology
|
| O: -1.06%
H: 2.28%
C: 1.85%
treatment gene therapy therapy gene therapies
Praxis Precision Medicines Receives Orphan Drug Designation for PRAX-562 for the Treatment of SCN2A-DEE
Published: 2021-04-30 (Crawled : 13:15) - globenewswire.com
PRAX | $46.88 0.62% 0.62% 350K
|
Health Technology
|
| O: -2.42%
H: 1.4%
C: -2.48%
treatment drug designation
Legend Biotech Announces Submission of European Marketing Authorisation Application for BCMA CAR-T Therapy Ciltacabtagene Autoleucel (cilta-cel) for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Published: 2021-04-30 (Crawled : 12:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -0.37%
H: 0.8%
C: 0.33%
treatment europe therapy car-t biotech iot submission cel
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Opdivo (nivolumab) as Adjuvant Treatment for Patients with Muscle-Invasive Urothelial Carcinoma
Published: 2021-04-30 (Crawled : 12:00) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -1.42%
H: 1.23%
C: 0.68%
food treatment drug application nivolumab urothelial carcinoma
Analyzing COVID-19 Impact on Fracking Water Treatment Market | $ 1.12 Billion Growth Expected During 2021-2025 | Technavio
Published: 2021-04-30 (Crawled : 08:00) - prnewswire.com
XYL | $127.84 0.53% 0.0% 2.2M
|
Producer Manufacturing
|
| O: -0.69%
H: 0.39%
C: -0.75%
covid treatment growth
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.